The Prodia CRO team attended the launch of the Indonesia Clinical Research Center (INA-CRC) which was inaugurated by the Ministry of Health of the Republic of Indonesia at the Eijkman Building, dr. Cipto Mangunkusumo Hospital (RSCM) on October 16, 2024. The INA-CRC launch was attended by Prodia the CRO’s team, represented by Erizal Sugino (Director) and Ida Paulina (SMO Manager).
This is a significant leap as part of the transformation of clinical research in Indonesia. In order to facilitate and coordinate Clinical Research Units (CRU) in all Indonesian hospitals, INA CRC was founded in accordance with the Decree of the Minister of Health of the Republic of Indonesia No. HK.01.07/MENKES/1458/2023 about the Implementation of Clinical Research in Hospitals.
INA-CRC will boost Indonesia as regional clinical research hub whileplaya a role in the advancement of the transformation of clinical research in Indonesia. INA CRC is dedicated to improving national competitiveness in the health sector, driving health innovation, and emerging as a major force in international clinical research. Additionally, it will make Indonesia more competitive and appealing to both domestic and foreign enterprises as a clinical research site. The Indonesian Minister of Health said that INA CRC is the missing piece of clinical trial and health innovation in Indonesia.
Furthermore, Prodia the CRO believes that clinical trials in Indonesia may be transformed and synergized with a strong commitment from every stakeholder. According to Dr. Ida Paulina, Site Management Manager of Prodia the CRO, INA CRC is a collective aspiration that has now come into reality and is anticipated to improve clinical research unit among hospitals in Indonesia. INA CRC is expected to contribute significantly to the advancement of medical innovation in Indonesia. Prodia the CRO gives its utmost commitment working with INA CRC in delivering highest quality for clinical trials through clinical research unit establishment in hospitals across Indonesia. As the first actions after its inauguration, INA-CRC launch the initiative to transform clinical trial implementation in Indonesian. Those are the re-branding Indonesian clinical registry and simplified material transfer agreement (MTA) submission. With this transformation, sponsors will have certainty in both timeline and approval process.
About Prodi the CRO. Prodia the CRO is a Contract Research Organization (CRO) based in Indonesia which provides GCP-based Clinical Trial supports through our integrated and wide range of services. Prodia the CRO has accumulated many experiences providing services to local as well as multinational companies with commitment to reach quality through qualified and dedicated resources. It provides customers in GCP trials with competitive costs, firm timeliness, high compliance to ICH-GCP guidelines.
